KRO-07850
5-amino-3-(4-phenoxyphenyl)-1h-pyrazole-4-carbonitrile
330792-70-6
98% min.
scale-up (10-1,000 kg)
C16H12N4O
5-amino-3-(4-phenoxyphenyl)-1h-pyrazole-4-carbonitrile
98% min.
scale-up (10-1,000 kg)
C16H12N4O
5-amino-3-(4-phenoxyphenyl)-1h-pyrazole-4-carbonitrile
KRO-00666
(1s,3r,20r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxyprop-1''(e)-enyl)-9,10-secopregna-5(e),7(e),10(19)-triene
112849-17-9
98% min.
scale-up (10-1,000 kg)
C39H66O3Si2
(1s,3r,20r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxyprop-1''(e)-enyl)-9,10-secopregna-5(e),7(e),10(19)-triene; 2-penten-1-one,4-[(1r,3as,4e,7ar)-4-[(2e)-2-[(3s,5r)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1h-inden-1-yl]-1-cyclopropyl-,(2e,4r); (5e)-1,3-bis-o-(tert-butyldimethylsilyl)-24-oxo-calcipotriene; (1a,3b,5e,7e,22e)-24-cyclopropyl-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-one; (r,e)-4-((1r,3as,7ar,e)-4-((e)-2-((3s,5r)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1h-inden-1-yl)-1-cyclopropylpent-2-en-1-one; 1(s),3(r).20(r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxyprop-1''(e)-enyl)-9,10-secopregna-5(e),10(19)triene; 20(r),1(s),3(r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxoprop-1''(e)-enyl)-9,10-secopregna-5(e),7(e),10(19)-triene
98% min.
scale-up (10-1,000 kg)
C39H66O3Si2
(1s,3r,20r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxyprop-1''(e)-enyl)-9,10-secopregna-5(e),7(e),10(19)-triene; 2-penten-1-one,4-[(1r,3as,4e,7ar)-4-[(2e)-2-[(3s,5r)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1h-inden-1-yl]-1-cyclopropyl-,(2e,4r); (5e)-1,3-bis-o-(tert-butyldimethylsilyl)-24-oxo-calcipotriene; (1a,3b,5e,7e,22e)-24-cyclopropyl-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-one; (r,e)-4-((1r,3as,7ar,e)-4-((e)-2-((3s,5r)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1h-inden-1-yl)-1-cyclopropylpent-2-en-1-one; 1(s),3(r).20(r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxyprop-1''(e)-enyl)-9,10-secopregna-5(e),10(19)triene; 20(r),1(s),3(r)-bis(tert-butyldimethylsilyloxy)-20-(3''-cyclopropyl-3''-oxoprop-1''(e)-enyl)-9,10-secopregna-5(e),7(e),10(19)-triene
KRO-00079
5-(4-bromophenyl)-pyrimidine-4,6-diol
706811-25-8
98% min.
scale-up (10-1,000 kg)
C10H7BrN2O2
5-(4-bromophenyl)-pyrimidine-4,6-diol; 5-(4-bromophenyl)-oxazole; oxazole,5-(4-bromophenyl)
98% min.
scale-up (10-1,000 kg)
C10H7BrN2O2
5-(4-bromophenyl)-pyrimidine-4,6-diol; 5-(4-bromophenyl)-oxazole; oxazole,5-(4-bromophenyl)
KRO-09716
4-[(1r)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]cyclohexane-1-carboxylic acid
671815-99-9
98% min.
scale-up (10-1,000 kg)
C14H25NO4
4-[(1r)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]cyclohexane-1-carboxylic acid
98% min.
scale-up (10-1,000 kg)
C14H25NO4
4-[(1r)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]cyclohexane-1-carboxylic acid
KRO-04948
[3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2e,4e-pentadiene]triphenyl phosphonium bromide
62285-98-7
98% min.
scale-up (10-1,000 kg)
C33H38BrP
[3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2e,4e-pentadiene]triphenyl phosphonium bromide; ((2e,4e)-3-methyl-5-(2,6,6-trimethylcyclohex-2-en-1-yl)penta-2,4-dien-1-yl)triphenylphosphonium bromide; <3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienyl>triphenylphosphonium bromide; 5-(2,6,6-trimethylcyclohexenyl)-3-methyl-2,4-pentadienyltriphenylphosphonium bromide; (all-e)-5-(2,6,6-trimethylcyclohex-1-enyl)-3-methyl-2,4-pentadienylphosphonium bromide; [(2e,4e)-3-methyl-5-(2,6,6-trimethylcyclohex-2-en-1-yl)penta-2,4-dienyl]-triphenylphosphanium,bromide
98% min.
scale-up (10-1,000 kg)
C33H38BrP
[3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2e,4e-pentadiene]triphenyl phosphonium bromide; ((2e,4e)-3-methyl-5-(2,6,6-trimethylcyclohex-2-en-1-yl)penta-2,4-dien-1-yl)triphenylphosphonium bromide; <3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienyl>triphenylphosphonium bromide; 5-(2,6,6-trimethylcyclohexenyl)-3-methyl-2,4-pentadienyltriphenylphosphonium bromide; (all-e)-5-(2,6,6-trimethylcyclohex-1-enyl)-3-methyl-2,4-pentadienylphosphonium bromide; [(2e,4e)-3-methyl-5-(2,6,6-trimethylcyclohex-2-en-1-yl)penta-2,4-dienyl]-triphenylphosphanium,bromide
KRO-10760
n4-benzoyl-1-(s)-(3-hydroxy-2-phosphonomethoxypropyl)cytosine
132336-37-9
98% min.
scale-up (10-1,000 kg)
C15H18N3O7P
n4-benzoyl-1-(s)-(3-hydroxy-2-phosphonomethoxypropyl)cytosine; (s)-(((1-(4-benzamido-2-oxopyrimidin-1(2h)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
98% min.
scale-up (10-1,000 kg)
C15H18N3O7P
n4-benzoyl-1-(s)-(3-hydroxy-2-phosphonomethoxypropyl)cytosine; (s)-(((1-(4-benzamido-2-oxopyrimidin-1(2h)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
KRO-27794
phenyl {4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl}carbamate
184177-81-9
98% min.
scale-up (10-1,000 kg)
C23H23N3O3
phenyl {4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl}carbamate; 4-[4-(4-hydroxy-phenyl)-piperazin-1-yl]-phenyl-carbamic acid phenyl ester; phenyl {4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}carbamate
98% min.
scale-up (10-1,000 kg)
C23H23N3O3
phenyl {4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl}carbamate; 4-[4-(4-hydroxy-phenyl)-piperazin-1-yl]-phenyl-carbamic acid phenyl ester; phenyl {4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}carbamate
KRO-00452
2-benzylidene isobutyryl acetanilide
125971-57-5
98% min.
scale-up (10-1,000 kg)
C19H19NO2
2-benzylidene isobutyryl acetanilide; 2-isobutyryl-n,3-diphenylacrylamide; 2-isobutyryl-n,3-diphenylacrylamide; 2-benzylidene-4-methyl-3-oxo-n-phenylpentanamide
98% min.
scale-up (10-1,000 kg)
C19H19NO2
2-benzylidene isobutyryl acetanilide; 2-isobutyryl-n,3-diphenylacrylamide; 2-isobutyryl-n,3-diphenylacrylamide; 2-benzylidene-4-methyl-3-oxo-n-phenylpentanamide
KRO-07851
(r)-3-(4-phenoxyphenyl)-1-(piperidine-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4
98% min.
scale-up (10-1,000 kg)
C22H22N6O
(r)-3-(4-phenoxyphenyl)-1-(piperidine-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine; btk inhibitor 1 r enantiomer; 3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine; benzenepropanoic acid,4-fluoro-b-methyl-,(br); (r)-3-(4-fluorophenyl)butanoic acid; (r)-3-(p-fluorophenyl)butanoic acid; 3-(4-phenoxy-phenyl)-1-piperidin-3-yl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine; (r)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
98% min.
scale-up (10-1,000 kg)
C22H22N6O
(r)-3-(4-phenoxyphenyl)-1-(piperidine-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine; btk inhibitor 1 r enantiomer; 3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine; benzenepropanoic acid,4-fluoro-b-methyl-,(br); (r)-3-(4-fluorophenyl)butanoic acid; (r)-3-(p-fluorophenyl)butanoic acid; 3-(4-phenoxy-phenyl)-1-piperidin-3-yl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine; (r)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
KRO-05907
ethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
139481-58-6
98% min.
scale-up (10-1,000 kg)
C26H24N6O3
ethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
98% min.
scale-up (10-1,000 kg)
C26H24N6O3
ethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
KRO-33889
n,n-dimethyl-2-methyl-3-(3-methoxyphenyl)valeramide
1313374-17-2
98% min.
scale-up (10-1,000 kg)
C15H23NO2
n,n-dimethyl-2-methyl-3-(3-methoxyphenyl)valeramide; 3-(3-methoxy-phenyl)-2-methyl-pentanoic acid dimethylamide
98% min.
scale-up (10-1,000 kg)
C15H23NO2
n,n-dimethyl-2-methyl-3-(3-methoxyphenyl)valeramide; 3-(3-methoxy-phenyl)-2-methyl-pentanoic acid dimethylamide
KRO-04791
epi-secopenicillin
67977-61-1
98% min.
scale-up (10-1,000 kg)
C28H24N2O4
epi-secopenicillin; r-4trmp
98% min.
scale-up (10-1,000 kg)
C28H24N2O4
epi-secopenicillin; r-4trmp
KRO-03936
saxagliptin hcl salt
709031-78-7
98% min.
scale-up (10-1,000 kg)
C18H26ClN3O2
saxagliptin hcl salt; saxagliptin hcl
98% min.
scale-up (10-1,000 kg)
C18H26ClN3O2
saxagliptin hcl salt; saxagliptin hcl
KRO-45991
1-(cyclopropanecarbonyl)piperazine 97
59878-57-8
98% min.
scale-up (10-1,000 kg)
C8H14N2O
1-(cyclopropanecarbonyl)piperazine 97
98% min.
scale-up (10-1,000 kg)
C8H14N2O
1-(cyclopropanecarbonyl)piperazine 97
KRO-15595
2-methyl-2-propanyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(1h)-carbo xylate
1280210-79-8
98% min.
scale-up (10-1,000 kg)
C10H15N3O2
2-methyl-2-propanyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(1h)-carbo xylate
98% min.
scale-up (10-1,000 kg)
C10H15N3O2
2-methyl-2-propanyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(1h)-carbo xylate
KRO-45761
hexahydro-1-methyl-4h-azepin-4-one
19869-42-2
98% min.
scale-up (10-1,000 kg)
C7H14ClNO
hexahydro-1-methyl-4h-azepin-4-one
98% min.
scale-up (10-1,000 kg)
C7H14ClNO
hexahydro-1-methyl-4h-azepin-4-one
KRO-27508
42075-29-6
98% min.
scale-up (10-1,000 kg)
C11H13NO3
98% min.
scale-up (10-1,000 kg)
C11H13NO3
KRO-01032
di-tert-butyl (2s,2''s)-2,2''-(4,4''-biphenyldiylbis(lh-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate)
1007882-23-6
98% min.
scale-up (10-1,000 kg)
C36H44N6O4
di-tert-butyl (2s,2''s)-2,2''-(4,4''-biphenyldiylbis(lh-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate); daclatasvir intermediate; di-tert-butyl(2s,2''s)-2,2''-(4,4''-biphenyldiylbis(1h-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate)
98% min.
scale-up (10-1,000 kg)
C36H44N6O4
di-tert-butyl (2s,2''s)-2,2''-(4,4''-biphenyldiylbis(lh-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate); daclatasvir intermediate; di-tert-butyl(2s,2''s)-2,2''-(4,4''-biphenyldiylbis(1h-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate)
KRO-00377
(3r)-3-(4-((5-bromo-2-chlorophenyl)methyl)phenoxy)tetrahydrofuran
915095-90-8
98% min.
scale-up (10-1,000 kg)
C17H16BrClO2
(3r)-3-(4-((5-bromo-2-chlorophenyl)methyl)phenoxy)tetrahydrofuran
98% min.
scale-up (10-1,000 kg)
C17H16BrClO2
(3r)-3-(4-((5-bromo-2-chlorophenyl)methyl)phenoxy)tetrahydrofuran
KRO-04916
(1s,2s,3s,5s)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol
142217-77-4
98% min.
scale-up (10-1,000 kg)
C32H33N5O4
(1s,2s,3s,5s)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol
98% min.
scale-up (10-1,000 kg)
C32H33N5O4
(1s,2s,3s,5s)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol